TNON
Income statement / Annual
Last year (2023), Tenon Medical, Inc.'s total revenue was $2.93 M,
an increase of 323.73% from the previous year.
In 2023, Tenon Medical, Inc.'s net income was -$15.58 M.
See Tenon Medical, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$2.93 M
|
$691,000.00
|
$159,800.00
|
$43,820.00
|
$53,640.00
|
| Cost of Revenue |
$1.69 M |
$1.33 M |
$54,772.00 |
$18,257.00 |
$18,257.00 |
| Gross Profit |
$1.24 M |
-$641,000.00 |
$105,028.00 |
$25,563.00 |
$35,383.00 |
| Gross Profit Ratio |
0.42 |
-0.93 |
0.66 |
0.58 |
0.66 |
| Research and Development
Expenses |
$3.16 M
|
$2.83 M
|
$1.72 M
|
$220,884.00
|
$371,545.00
|
| General & Administrative
Expenses |
$7.03 M
|
$7.42 M
|
$2.71 M
|
$311,667.00
|
$171,662.00
|
| Selling & Marketing
Expenses |
$6.78 M
|
$7.83 M
|
$2.14 M
|
$29,301.00
|
$25,618.00
|
| Selling, General &
Administrative Expenses |
$13.81 M
|
$15.26 M
|
$4.85 M
|
$340,968.00
|
$197,280.00
|
| Other Expenses |
$0.00 |
-$18,000.00 |
-$1,233.00 |
-$1,230.00 |
$0.00 |
| Operating Expenses |
$16.97 M |
$18.08 M |
$6.57 M |
$561,852.00 |
$568,825.00 |
| Cost And Expenses |
$18.66 M |
$19.42 M |
$6.62 M |
$580,109.00 |
$587,082.00 |
| Interest Income |
$0.00 |
$174,000.00 |
$619,000.00 |
$167,846.00 |
$52,358.00 |
| Interest Expense |
$21,000.00 |
$354,000.00 |
$620,808.00 |
$167,846.00 |
$52,358.00 |
| Depreciation &
Amortization |
$199,000.00
|
$289,000.00
|
$113,980.00
|
$536,289.00
|
$533,442.00
|
| EBITDA |
-$15.53 M
|
-$18.45 M
|
-$6.35 M
|
-$537,519.00
|
-$533,440.00
|
| EBITDA Ratio |
-5.3 |
-26.71 |
-39.72 |
-12.27 |
-9.94 |
| Operating Income Ratio
|
-5.37
|
-27.1
|
-40.43
|
-12.24
|
-9.94
|
| Total Other
Income/Expenses Net |
$146,000.00
|
-$192,000.00
|
-$620,012.00
|
-$169,076.00
|
-$52,388.00
|
| Income Before Tax |
-$15.58 M |
-$18.92 M |
-$7.08 M |
-$705,365.00 |
-$585,828.00 |
| Income Before Tax Ratio
|
-5.32
|
-27.38
|
-44.31
|
-16.1
|
-10.92
|
| Income Tax Expense |
$0.00 |
$192,000.00 |
$587,239.00 |
$47,659.00 |
-$609,690.00 |
| Net Income |
-$15.58 M |
-$19.11 M |
-$7.67 M |
-$753,024.00 |
-$509,580.00 |
| Net Income Ratio |
-5.32 |
-27.65 |
-47.98 |
-17.18 |
-9.5 |
| EPS |
-68.71 |
-23.86 |
-6.82 |
-0.67 |
-0.45 |
| EPS Diluted |
-68.71 |
-23.86 |
-6.82 |
-0.67 |
-0.45 |
| Weighted Average Shares
Out |
$226,750.00
|
$800,800.00
|
$1.12 M
|
$1.12 M
|
$1.12 M
|
| Weighted Average Shares
Out Diluted |
$226,750.00
|
$800,800.00
|
$1.12 M
|
$1.12 M
|
$1.12 M
|
| Link |
|
|
|
|
|
